About
Dapagliflozin is an oral medication belonging to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is primarily used to improve glycemic control in adults with type 2 diabetes mellitus. Its unique mechanism of action involves inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the filtered blood back into the bloodstream. By blocking SGLT2, Dapagliflozin promotes the excretion of excess glucose in the urine, thereby lowering blood glucose levels independently of insulin secretion.
Beyond its glucose-lowering effects, Dapagliflozin has demonstrated significant cardiovascular and renal benefits. It can reduce the risk of cardiovascular death and hospitalization for heart failure in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors. Furthermore, it slows the progression of kidney disease in patients with chronic kidney disease, making it a valuable therapeutic option for comprehensive diabetes management.
Uses
- Treatment of type 2 diabetes mellitus
- Reduction of cardiovascular risk in high-risk patients
- Reduction of hospitalization for heart failure
- Slowing the progression of chronic kidney disease
Directions For Use
Take orally once daily in the morning, with or without food. Swallow the tablet whole with water.
Benefits
- Effectively lowers blood glucose levels
- Promotes modest weight loss
- Reduces blood pressure
- Provides significant cardiovascular protection
- Offers renoprotective effects
- Low risk of hypoglycemia (as monotherapy)
Side Effects
- Genital yeast infections
- Urinary tract infections
- Increased urination
- Thirst
- Dizziness
- Hypotension (low blood pressure)
- Diabetic ketoacidosis (rare, serious)
- Kidney problems
- Fournier's gangrene (very rare, serious)
- Back pain
- Dyslipidemia
- Nasopharyngitis
Safety Measures
- Alcohol - Limit alcohol intake as it may increase the risk of diabetic ketoacidosis, especially in susceptible individuals.
- Pregnancy - Not recommended, particularly during the second and third trimesters, due to potential adverse effects on fetal kidney development.
- Breastfeeding - Not advised as there is a potential for adverse effects in breastfed infants. Discuss alternatives with your doctor.
- Liver - Use with caution in patients with severe hepatic impairment; dosage adjustment may be considered.
- Kidney - Not recommended for patients with severe renal impairment (eGFR <25 mL/min/1.73m²) or those on dialysis.
- Lung - Generally safe for patients with lung conditions; no specific lung-related contraindications are known.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!